| Lisa Rhynes, ARNP-CNP | |
|
1921 Stonecipher Blvd, Ada, OK 74820 | |
| (580) 421-4570 | |
| Not Available |
| Full Name | Lisa Rhynes |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 22 Years |
| Location | 1921 Stonecipher Blvd, Ada, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649259458 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 69780 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chickasaw Nation Medical Center | Ada, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chickasaw Nation Division Of Health | 8426957523 | 209 |
News Archive
Administering the drug rituximab once weekly for one month provides the same benefits as 18 months of daily immunosuppressive therapy in people with severe forms of vasculitis, or inflammation of the blood vessels, a study has found.
Steven E. Nissen, M.D., of the Cleveland Clinic, and colleagues identified patients with muscle-related adverse effects from statins and compared lipid-lowering efficacy for two nonstatin therapies, ezetimibe and evolocumab. The study was published online by JAMA, and is being released to coincide with its presentation at the American College of Cardiology's 65th Annual Scientific Session & Expo.
New data from the World Health Organization (WHO) show that the GAVI Alliance, a groundbreaking global initiative to increase access to children's vaccines, has brought immunisation rates to record highs in poor countries.
While many researchers believe that the Hedgehog (Hh) signaling pathway, which transmits information to embryonic cells for proper development and is important for regeneration, may actually regulate cell-cell adhesion and segregation - there isn't any evidence.
The National Comprehensive Cancer Network Oncology Research Program has funded two investigators from NCCN Member Institutions through a collaborative scientific research relationship with AstraZeneca to further evaluate the clinical effectiveness of osimertinib in the treatment of epidermal growth factor receptor-positive (EGFRm+) non-small cell lung cancer (NSCLC).
› Verified 5 days ago
| Entity Name | Chickasaw Nation Division Of Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255364923 PECOS PAC ID: 8426957523 Enrollment ID: O20040108000364 |
News Archive
Administering the drug rituximab once weekly for one month provides the same benefits as 18 months of daily immunosuppressive therapy in people with severe forms of vasculitis, or inflammation of the blood vessels, a study has found.
Steven E. Nissen, M.D., of the Cleveland Clinic, and colleagues identified patients with muscle-related adverse effects from statins and compared lipid-lowering efficacy for two nonstatin therapies, ezetimibe and evolocumab. The study was published online by JAMA, and is being released to coincide with its presentation at the American College of Cardiology's 65th Annual Scientific Session & Expo.
New data from the World Health Organization (WHO) show that the GAVI Alliance, a groundbreaking global initiative to increase access to children's vaccines, has brought immunisation rates to record highs in poor countries.
While many researchers believe that the Hedgehog (Hh) signaling pathway, which transmits information to embryonic cells for proper development and is important for regeneration, may actually regulate cell-cell adhesion and segregation - there isn't any evidence.
The National Comprehensive Cancer Network Oncology Research Program has funded two investigators from NCCN Member Institutions through a collaborative scientific research relationship with AstraZeneca to further evaluate the clinical effectiveness of osimertinib in the treatment of epidermal growth factor receptor-positive (EGFRm+) non-small cell lung cancer (NSCLC).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Rhynes, ARNP-CNP 1921 Stonecipher Blvd, Ada, OK 74820 Ph: (580) 421-4570 | Lisa Rhynes, ARNP-CNP 1921 Stonecipher Blvd, Ada, OK 74820 Ph: (580) 421-4570 |
News Archive
Administering the drug rituximab once weekly for one month provides the same benefits as 18 months of daily immunosuppressive therapy in people with severe forms of vasculitis, or inflammation of the blood vessels, a study has found.
Steven E. Nissen, M.D., of the Cleveland Clinic, and colleagues identified patients with muscle-related adverse effects from statins and compared lipid-lowering efficacy for two nonstatin therapies, ezetimibe and evolocumab. The study was published online by JAMA, and is being released to coincide with its presentation at the American College of Cardiology's 65th Annual Scientific Session & Expo.
New data from the World Health Organization (WHO) show that the GAVI Alliance, a groundbreaking global initiative to increase access to children's vaccines, has brought immunisation rates to record highs in poor countries.
While many researchers believe that the Hedgehog (Hh) signaling pathway, which transmits information to embryonic cells for proper development and is important for regeneration, may actually regulate cell-cell adhesion and segregation - there isn't any evidence.
The National Comprehensive Cancer Network Oncology Research Program has funded two investigators from NCCN Member Institutions through a collaborative scientific research relationship with AstraZeneca to further evaluate the clinical effectiveness of osimertinib in the treatment of epidermal growth factor receptor-positive (EGFRm+) non-small cell lung cancer (NSCLC).
› Verified 5 days ago
Akilah Talibah Dunn, APRN-CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1921 Stonecipher Blvd., Ada, OK 74820 Phone: 580-436-3980 | |
Mrs. Linda Louise Spooner, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2330 Arlington St, Ada, OK 74820 Phone: 580-332-2011 Fax: 580-332-9537 | |
Dr. Tosha Lucille Wilson, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 709 Better Now Plz, Ada, OK 74820 Phone: 580-310-9989 | |
Qiong Mu Ross, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 905 Colony Dr, Ada, OK 74820 Phone: 580-436-5111 Fax: 580-436-1159 | |
Robin M Losee, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1921 Stonecipher Blvd, Ada, OK 74820 Phone: 580-421-4570 | |
Michelle Ann Cole, APRN FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 709 Better Now Plz, Ada, OK 74820 Phone: 580-310-9899 Fax: 580-310-9818 | |
Shari M Rhodes, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1201 Arlington St Ste F, Ada, OK 74820 Phone: 580-279-1788 |